Ebola Vaccine Trial
- All
- News
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
New Ebola Vaccine Safe, Stimulates Strong Immune Response
A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.
-
China-Made Ebola Vaccine Permitted for Overseas Trial
A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Vaccine Offers 100% Ebola Protection: Trial Results
An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.
-
Needle-Free, Inhalable Vaccine Developed for Ebola
The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.
-
Ghana Halts Ebola Vaccine Trial Due to Community Protests
Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.
-
Indian-Origin Researcher Helps in Ebola Vaccine Trials
An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Vaccines Trial Starts in Liberia
A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.
-
Trial for Ebola Vaccine Starts in Liberia
A trial of an Ebola vaccine was to start Monday in Liberia's capital following a launch event featuring musicians.
-
Ebola Vaccine is Safe, Say Researchers
Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
New Ebola Vaccine Safe, Stimulates Strong Immune Response
A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.
-
China-Made Ebola Vaccine Permitted for Overseas Trial
A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Vaccine Offers 100% Ebola Protection: Trial Results
An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.
-
Needle-Free, Inhalable Vaccine Developed for Ebola
The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.
-
Ghana Halts Ebola Vaccine Trial Due to Community Protests
Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.
-
Indian-Origin Researcher Helps in Ebola Vaccine Trials
An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Vaccines Trial Starts in Liberia
A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.
-
Trial for Ebola Vaccine Starts in Liberia
A trial of an Ebola vaccine was to start Monday in Liberia's capital following a launch event featuring musicians.
-
Ebola Vaccine is Safe, Say Researchers
Preliminary results from a clinical trial on an experimental Ebola vaccine developed by GlaxoSmithKline and the US National Institutes of Health suggest it is safe for use, researchers said on Wednesday.
